拨康视云及参天制药宣布就翼状胬肉创新药CBT-001签订授权协议

Santen and Cloudbreak execute a new licensing agreement for CBT-001, a topical treatment of pterygium   6 August 2024 – Osaka, Japan – Santen Pharmaceutical Co., Ltd. (head office: Osaka, Japan; hereinafter Santen), a specialist in ophthalmology, and Cloudbreak Pharma Inc. (head office: California, US; hereinafter Cloudbreak), a clinical stage ophthalmic drug company, announce the […]